JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meezan, E.
Right arrow Articles by Brendel, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meezan, E.
Right arrow Articles by Brendel, K.
Journal of Pharmacology And Experimental Therapeutics, Vol. 187, Issue 2, 352-364, 1973
Copyright © 1973 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF ETHACRYNIC ACID ON OXIDATIVE METABOLISM IN ISOLATED GLOMERULI

Elias Meezan 1 and Klaus Brendel 1

1 Department of Pharmacology, University of Arizona Medical Center, Tucson, Arizona

The effects of ethacrynic acid on oxidative metabolism were studied in preparations of pure isolated rat kidney glomeruli obtained with the use of magnetic iron oxide. Ethacrynic acid inhibited the oxidation of oleate, succinate, glucose, lactate, citrate, aspartate and glutamate at concentrations of drug of 1x10-4 M or greater, as measured by the conversion of labeled substrates to 14CO2. A small but significant stimulation of oleic acid oxidation was observed at ethacrynic acid concentrations of less than 2x10-5 M. Ethacrynic acid markedly inhibited oleic acid oxidation at a concentration of 5x10-4 M while ouabain and furosemide at this concentration caused little or no inhibition. Modification of the aliphatic carbon-carbon double bond of the ethacrynic acid molecule by treatment with H2S, H2O2 or hydrogenation resulted in a marked reduction or loss of the inhibitory properties of the compound. The inhibition of oleic acid oxidation could be prevented by the presence during incubation of a number of sulfhydryl-containing compounds. Later addition of a sulfhydryl compound to the incubation could only delay somewhat, but not prevent or overcome, the inhibition induced by ethacrynic acid. Ethacrynic acid is therefore a potent inhibitor of oxidative metabolism in isolated glomeruli and requires an intact activated double bond for inhibition. The inhibition can be blocked by agents containing free sulfhydryl groups, but whether the metabolic inhibition induced by the drug is due to its reactivity with such groups is not known.

Submitted on February 2, 1973
Accepted on June 8, 1973







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics.